XIAOFEN LI,JEFF ZABLOCKI,BRITTON KENNETH CORKEY,ELFATIH ELZEIN,RAO V. KALLA,DMITRY KOLTUN,ERIC Q. PARKHILL,THAO PERRY,ROBERT H. JIANG,RUBEN MARTINEZ,CHANDRASEKAR VENKATARAMANI,MICHAEL GRAUPE,JUAN GUER
申请号：
PT15177723
公开号：
PT2966067T
申请日:
2012.06.29
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
The present disclosure relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein Y, Z, n, R1 and R3 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.
